Mizuho Reaffirms “Outperform” on Harmony Biosciences (HRMY) for BP1.15205 Data

finance.yahoo.com/news/mizuho-reaffirms-outperform-harmony-biosciences-153050542.html

In This Article:
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the 7 most undervalued pot stocks to buy according to analysts. On June 23, Mizuho reiterated its “Outperform” rating on Harmony and maintained a price target of $48. The reaffirmation followed Harmony’s…

This story appeared on finance.yahoo.com, 2025-07-14 15:30:50.
The Entire Business World on a Single Page. Free to Use →